What is Advanced Oxygen Technologies I's earnings per share (EPS)?

Advanced Oxygen Technologies I (AOXY) reported diluted earnings per share of $0.00 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Advanced Oxygen Technologies I Financials

AOXY

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE June

This page shows Advanced Oxygen Technologies I (AOXY) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AOXY FY2025 2026-05-12

Balance-sheet repair, not sales expansion, is the main visible mechanic as operating cash flow funds deleveraging.

Across the last three years, operating cash flow consistently exceeded net income while total liabilities fell to $277K, so the cash the business produces seems to be going mainly into balance-sheet cleanup rather than expansion. That matters because book equity sits beside a retained deficit of -$20.8M, which implies today’s net worth comes more from capital structure repair than from profits accumulated over time.

The long-term debt load was reduced from $127K to $0 since FY2024, but liquidity remains tight: current assets still cover well under half of current obligations. Debt reduction improved solvency, but the liability stack is now more concentrated in the short term, so cash timing still matters even without leverage.

With revenue only $43K against assets of $693K, income-statement margins are less informative than funding posture; this is a business where balance-sheet timing matters more than sales throughput. Operating margin stayed above 30.0% in two of the last three years, yet returns on assets remained thin, showing that the constraint is not cost control alone but the very small revenue base relative to the asset footprint.

Financial Health Signals

Financial health score pending refresh

We are recalculating Advanced Oxygen Technologies I's peer-relative financial health score against the latest fiscal year. It will appear here once the refresh completes. The signals and metrics below are current.

Altman Z-Score Distress

-41.24

Advanced Oxygen Technologies I scores -41.24, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($329K) relative to total liabilities ($277K). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

Advanced Oxygen Technologies I passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

9.77x

For every $1 of reported earnings, Advanced Oxygen Technologies I generates $9.77 in operating cash flow ($40K OCF vs $4K net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$43K

YoY+2.0%

5Y CAGR+0.1%

10Y CAGR+1.2%

Advanced Oxygen Technologies I generated $43K in revenue in fiscal year 2025. This represents an increase of 2.0% from the prior year.

EBITDA

N/A

Net Income

$4K

YoY-25.6%

10Y CAGR-13.8%

Advanced Oxygen Technologies I reported $4K in net income in fiscal year 2025. This represents a decrease of 25.6% from the prior year.

EPS (Diluted)

$0.00

Advanced Oxygen Technologies I earned $0.00 per diluted share (EPS) in fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$57K

YoY-39.4%

5Y CAGR+5.6%

10Y CAGR-1.7%

Advanced Oxygen Technologies I held $57K in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+0.0%

5Y CAGR+0.0%

10Y CAGR+3.7%

Advanced Oxygen Technologies I had 3M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

31.7%

YoY-2.2pp

5Y CAGR+244.9pp

Advanced Oxygen Technologies I's operating margin was 31.7% in fiscal year 2025, reflecting core business profitability. This is down 2.2 percentage points from the prior year.

Net Margin

9.5%

YoY-3.6pp

5Y CAGR+248.4pp

10Y CAGR-37.6pp

Advanced Oxygen Technologies I's net profit margin was 9.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 3.6 percentage points from the prior year.

Return on Equity

1.0%

YoY-0.6pp

5Y CAGR+34.7pp

10Y CAGR-6.0pp

Advanced Oxygen Technologies I's ROE was 1.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 0.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

AOXY Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$43K+2.0%	$43K+8.0%	$39K-0.3%	$40K-4.6%	$41K-4.0%	$43K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$7K+0.5%	$7K-5.4%	$7K-4.6%	$7K-15.2%	$9K+31.8%	$7K
Operating Income	$14K-4.7%	$14K+29.0%	$11K	N/A	$17K+118.1%	-$92K
Interest Expense	N/A	$296-61.6%	$771-60.3%	$2K-27.7%	$3K-18.4%	$3K
Income Tax	$10K+8.7%	$9K+12.5%	$8K+1.4%	$8K-2.4%	$8K+5.6%	$8K
Net Income	$4K-25.6%	$6K+145.0%	$2K-96.0%	$57K+891.9%	$6K+105.6%	-$103K
EPS (Diluted)	$0.00	$0.00	$0.00-100.0%	$0.02	$0.00+100.0%	$-0.03

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$12K+2.4%	$12K-0.5%	$12K+35.1%	$9K-17.6%	$11K-20.1%	$13K+21.8%	$11K+2.0%	$11K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$1K-29.1%	$2K+58.5%	$1K-20.2%	$2K+9.4%	$1K-2.0%	$2K-25.9%	$2K+21.7%	$2K
Operating Income	$6K+17.1%	$5K+631.7%	-$973-131.4%	$3K-39.3%	$5K-34.1%	$8K+456.2%	-$2K-143.5%	$5K
Interest Expense	N/A	N/A	N/A	N/A	N/A	$352	$0+100.0%	-$145
Income Tax	$3K+3.1%	$3K+2.1%	$2K+0.6%	$2K+7.7%	$2K-22.5%	$3K+27.9%	$2K+0.8%	$2K
Net Income	$3K+30.4%	$3K+176.9%	-$3K-635.8%	$643-77.2%	$3K-45.3%	$5K+215.1%	-$4K-264.8%	$3K
EPS (Diluted)	$0.00	$0.00	$0.00	N/A	$0.00	$0.00	$0.00	N/A

AOXY Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$693K+2.6%	$675K-3.2%	$698K+5.4%	$662K-5.0%	$697K+6.6%	$654K
Current Assets	$58K-38.8%	$96K-9.8%	$106K+11.2%	$95K+86.0%	$51K+14.4%	$45K
Cash & Equivalents	$57K-39.4%	$94K-9.9%	$105K+11.3%	$94K+88.5%	$50K+14.6%	$44K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$277K-16.7%	$333K-3.9%	$347K+1.3%	$343K-2.5%	$351K+1.0%	$348K
Current Liabilities	$150K-27.1%	$206K-6.2%	$220K+5.5%	$209K+5.8%	$197K-35.1%	$304K
Long-Term Debt	$0-100.0%	$127K-5.2%	$134K-11.2%	$151K-13.0%	$173K-8.0%	$189K
Total Equity	$416K+21.5%	$342K-2.5%	$351K+9.7%	$320K-7.6%	$346K+13.1%	$306K
Retained Earnings	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M+0.3%	-$20.8M0.0%	-$20.8M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$655K-2.3%	$670K-1.6%	$681K-1.7%	$693K+7.5%	$645K+2.5%	$629K-9.4%	$694K+2.8%	$675K
Current Assets	$36K+1.8%	$35K-24.6%	$47K-20.1%	$58K-0.7%	$59K-10.5%	$66K-26.3%	$89K-6.8%	$96K
Cash & Equivalents	$35K+2.0%	$34K-25.4%	$46K-20.4%	$57K-0.8%	$58K-10.6%	$65K-26.6%	$88K-6.9%	$94K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$256K+0.8%	$254K-5.3%	$268K-3.3%	$277K-4.8%	$291K-5.1%	$307K-5.7%	$326K-2.3%	$333K
Current Liabilities	$256K+0.8%	$254K-5.3%	$268K+78.4%	$150K-48.4%	$291K-5.1%	$307K-5.7%	$326K+57.9%	$206K
Long-Term Debt	$0	$0	$0	$0	$0-100.0%	$127K0.0%	$127K0.0%	$127K
Total Equity	$399K-4.2%	$416K+0.8%	$413K-0.7%	$416K+17.7%	$353K+9.7%	$322K-12.6%	$368K+7.7%	$342K
Retained Earnings	-$20.7M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M0.0%	-$20.8M

AOXY Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$40K-10.4%	$45K+27.5%	$35K-60.5%	$90K+137.6%	$38K+3.8%	$36K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	-$125
Financing Cash Flow	-$90K-69.5%	-$53K-81.7%	-$29K+12.4%	-$33K+0.7%	-$34K+5.3%	-$35K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$11K-21.6%	$15K+40.1%	$10K-24.5%	$14K+41.5%	$10K+34.4%	$7K-24.0%	$10K-30.5%	$14K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Financing Cash Flow	-$10K+63.5%	-$26K-18.4%	-$22K+13.9%	-$26K-36.3%	-$19K+24.6%	-$25K-25.6%	-$20K+14.4%	-$23K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

AOXY Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	31.7%-2.2pp	33.9%+5.5pp	28.4%	N/A	40.3%+253.5pp	-213.2%
Net Margin	9.5%-3.6pp	13.1%+7.3pp	5.8%-138.5pp	144.2%+130.4pp	13.9%+252.8pp	-238.9%
Return on Equity	1.0%-0.6pp	1.6%+1.0pp	0.7%-17.2pp	17.8%+16.2pp	1.7%+35.4pp	-33.7%
Return on Assets	0.6%-0.2pp	0.8%+0.5pp	0.3%-8.3pp	8.6%+7.8pp	0.8%+16.6pp	-15.8%
Current Ratio	0.39-0.1	0.46-0.0	0.48+0.0	0.46+0.2	0.26+0.1	0.15
Debt-to-Equity	0.00-0.4	0.37-0.0	0.38-0.1	0.47-0.0	0.50-0.1	0.62
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	50.4%+6.3pp	44.1%+52.4pp	-8.3%-43.8pp	35.5%-12.7pp	48.2%-10.2pp	58.4%+78.4pp	-20.0%-66.8pp	46.8%
Net Margin	28.7%+6.2pp	22.6%+51.8pp	-29.2%-36.6pp	7.4%-19.3pp	26.6%-12.3pp	38.9%+80.0pp	-41.1%-66.6pp	25.4%
Return on Equity	0.9%+0.2pp	0.6%+1.5pp	-0.8%-1.0pp	0.1%-0.7pp	0.8%-0.8pp	1.6%+2.8pp	-1.2%-2.0pp	0.8%
Return on Assets	0.5%+0.1pp	0.4%+0.9pp	-0.5%-0.6pp	0.1%-0.4pp	0.4%-0.4pp	0.8%+1.5pp	-0.6%-1.0pp	0.4%
Current Ratio	0.140.0	0.14-0.0	0.17-0.2	0.39+0.2	0.20-0.0	0.21-0.1	0.27-0.2	0.46
Debt-to-Equity	0.000.0	0.000.0	0.000.0	0.000.0	0.00-0.4	0.39+0.0	0.34-0.0	0.37
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: The current ratio is below 1.0 (0.39), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Frequently Asked Questions

What is Advanced Oxygen Technologies I's annual revenue?

Advanced Oxygen Technologies I (AOXY) reported $43K in total revenue for fiscal year 2025. This represents a 2.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Advanced Oxygen Technologies I's revenue growing?

Advanced Oxygen Technologies I (AOXY) revenue grew by 2% year-over-year, from $43K to $43K in fiscal year 2025.

Is Advanced Oxygen Technologies I profitable?

Yes, Advanced Oxygen Technologies I (AOXY) reported a net income of $4K in fiscal year 2025, with a net profit margin of 9.5%.

How much debt does Advanced Oxygen Technologies I have?

As of fiscal year 2025, Advanced Oxygen Technologies I (AOXY) had $57K in cash and equivalents against $0 in long-term debt.

What is Advanced Oxygen Technologies I's operating margin?

Advanced Oxygen Technologies I (AOXY) had an operating margin of 31.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Advanced Oxygen Technologies I's net profit margin?

Advanced Oxygen Technologies I (AOXY) had a net profit margin of 9.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Advanced Oxygen Technologies I's return on equity (ROE)?

Advanced Oxygen Technologies I (AOXY) has a return on equity of 1.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Advanced Oxygen Technologies I's operating cash flow?

Advanced Oxygen Technologies I (AOXY) generated $40K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Advanced Oxygen Technologies I's total assets?

Advanced Oxygen Technologies I (AOXY) had $693K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Advanced Oxygen Technologies I have outstanding?

Advanced Oxygen Technologies I (AOXY) had 3M shares outstanding as of fiscal year 2025.

What is Advanced Oxygen Technologies I's current ratio?

Advanced Oxygen Technologies I (AOXY) had a current ratio of 0.39 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Advanced Oxygen Technologies I's debt-to-equity ratio?

Advanced Oxygen Technologies I (AOXY) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Advanced Oxygen Technologies I's return on assets (ROA)?

Advanced Oxygen Technologies I (AOXY) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Advanced Oxygen Technologies I's Altman Z-Score?

Advanced Oxygen Technologies I (AOXY) has an Altman Z-Score of -41.24, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Advanced Oxygen Technologies I's Piotroski F-Score?

Advanced Oxygen Technologies I (AOXY) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Advanced Oxygen Technologies I's earnings high quality?

Advanced Oxygen Technologies I (AOXY) has an earnings quality ratio of 9.77x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.